Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase EARLY_PHASE1 3Phase 3 3Phase NA 2Phase 4 2Phase 1 1

Status

Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Hepatocellular Carcinoma With Portal Vein Thrombosis 1Carcinoma, Hepatocellular 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 258Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 145Surgical Procedures, Operative 134Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Radiotherapy, Intensity-Modulated 79Colonoscopy 79Specimen Handling 78Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Interventional × Carvedilol × Clear all
NCT06836778 2025-02-20

Comparative Study of Carvedilol Monotherapy Versus Combination Therapy With Endoscopic Variceal Ligation (EVL) for Primary Prophylaxis of Variceal Bleeding in Patients With Hepatocellular Carcinoma With High-Risk Esophageal Varices

Institute of Liver and Biliary Sciences, India

Phase NA Not yet recruiting
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01659346 2017-11-17

Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.

Institute of Liver and Biliary Sciences, India

Phase NA Withdrawn
Gastrointestinal

Hepatocellular Carcinoma With Portal Vein Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡